Elion Therapeutics
- Biotech or pharma, therapeutic R&D
Elion Therapeutics is making novel antifungals that address critical unmet needs in immune suppressed people. EL219, a novel polyene antifungal in Phase 2, was rationally designed to leverage broad spectrum activity of amphotericin B, while mitigating sterol-mediated toxicities.
)
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
)
){kind=logo}
){kind=logo}